FSD Pharma Joins The Stock Day Podcast to Discuss Their Expanding Revenue Potential

Phoenix, September 12th, 2019 (Newsfile Corp.) -- The Stock Day Podcast welcomed FSD Pharma (FSDDF)(“the Company”), a company focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the development of the highest quality indoor grown, pharmaceutical-grade cannabis. CEO, Dr. Raza Bokhari, joined Stock Day host Everett Jolly.